Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders??? Equity (Deficit) (Unaudited)

v3.23.3
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total
Balance at Dec. 31, 2021 $ 4 $ 125,479 $ (101,342) $ (70) $ 24,071
Balance (in Shares) at Dec. 31, 2021 37,387,472        
Exercise of common stock options 13 13
Exercise of common stock options (in Shares) 24,015        
Stock-based compensation expense 424 424
Foreign currency translation adjustment (9) (9)
Net loss (6,025) (6,025)
Balance at Mar. 31, 2022 $ 4 125,916 (107,367) (79) 18,474
Balance (in Shares) at Mar. 31, 2022 37,411,487        
Balance at Dec. 31, 2021 $ 4 125,479 (101,342) (70) 24,071
Balance (in Shares) at Dec. 31, 2021 37,387,472        
Net loss         (18,850)
Balance at Sep. 30, 2022 $ 4 126,966 (120,192) (327) 6,451
Balance (in Shares) at Sep. 30, 2022 37,432,204        
Balance at Mar. 31, 2022 $ 4 125,916 (107,367) (79) 18,474
Balance (in Shares) at Mar. 31, 2022 37,411,487        
Issuance of common stock warrants 72 72
Exercise of common stock options 6 6
Exercise of common stock options (in Shares) 12,846        
Stock-based compensation expense 491 491
Foreign currency translation adjustment (131) (131)
Net loss (7,335) (7,335)
Balance at Jun. 30, 2022 $ 4 126,485 (114,702) (210) 11,577
Balance (in Shares) at Jun. 30, 2022 37,424,333        
Exercise of common stock options 4 4
Exercise of common stock options (in Shares) 7,871        
Stock-based compensation expense 477 477
Foreign currency translation adjustment (117) (117)
Net loss (5,490) (5,490)
Balance at Sep. 30, 2022 $ 4 126,966 (120,192) (327) 6,451
Balance (in Shares) at Sep. 30, 2022 37,432,204        
Balance at Dec. 31, 2022 $ 4 127,693 (125,791) (440) $ 1,466
Balance (in Shares) at Dec. 31, 2022 37,442,663       37,442,663
Exercise of common stock options 85 $ 85
Exercise of common stock options (in Shares) 112,252        
Stock-based compensation expense 533 533
Foreign currency translation adjustment (33) (33)
Net loss (5,239) (5,239)
Balance at Mar. 31, 2023 $ 4 128,311 (131,030) (473) (3,188)
Balance (in Shares) at Mar. 31, 2023 37,554,915        
Balance at Dec. 31, 2022 $ 4 127,693 (125,791) (440) $ 1,466
Balance (in Shares) at Dec. 31, 2022 37,442,663       37,442,663
Net loss         $ (14,679)
Balance at Sep. 30, 2023 $ 4 142,077 (140,470) (877) $ 734
Balance (in Shares) at Sep. 30, 2023 41,275,216       41,275,216
Balance at Mar. 31, 2023 $ 4 128,311 (131,030) (473) $ (3,188)
Balance (in Shares) at Mar. 31, 2023 37,554,915        
Issuance of common stock and warrants, net of issuance costs 11,845 11,845
Issuance of common stock and warrants, net of issuance costs (in Shares) 3,125,000        
Exercise of common stock options   93     93
Exercise of common stock options (in Shares) 82,121        
Stock-based compensation expense 570 570
Exercise of common stock warrants
Exercise of common stock warrants (in Shares) 38,042        
Foreign currency translation adjustment (298) (298)
Net loss (5,033) (5,033)
Balance at Jun. 30, 2023 $ 4 140,819 (136,063) (771) 3,989
Balance (in Shares) at Jun. 30, 2023 40,800,078        
Reclassification of warrants 597 597
Exercise of common stock options, warrants and vesting of restricted stock units 56 56
Exercise of common stock options, warrants and vesting of restricted stock units (in Shares) 475,138        
Stock-based compensation expense 641 641
Issuance costs associated with common stock and warrants   (36)     (36)
Foreign currency translation adjustment (106) (106)
Net loss (4,407) (4,407)
Balance at Sep. 30, 2023 $ 4 $ 142,077 $ (140,470) $ (877) $ 734
Balance (in Shares) at Sep. 30, 2023 41,275,216       41,275,216